Results and discussion factor (GTF) that has also been implicated in the We used a previously described screen designed to isolate mechanism of action of certain promoter-specific TBP mutants defective for transcription activation 
activation.
To confirm the biochemical basis of these mutational shows that, in a mobility shift assay, TBP-E186D bound to the TATA box at wild-type levels, whereas binding of sity DNA oligonucleotide arrays [19] . Transcription of whereas transcription of PHO11 was significantly lower than in wild-type cells. Finally, PHO11 was the only gene 5382 genes was analyzed in cells expressing TBP-E186D or an isogenic wild-type strain in two independent experiaffected by the DNA binding surface mutants, F148L and L189S. Thus, these four genes displayed strikingly ments. Of 5382 genes analyzed, transcription of 911 genes was decreased 2-fold or greater in cells expressing TBPvariable sensitivities to mutations in different TBP interfaces. E186D. Thus, transcription of approximately 17% of yeast genes is compromised by the TBP-E186D mutation. In addition, transcription of 177 genes (3.3%) was increased
We next tested the effects of TBP-E186D on five well-2-fold or greater.
characterized transcriptionally inducible genes: GAL1, CUP1, SSA4 (HSP70), INO1, and HIS3. Figure 2b shows that, in cells expressing TBP-E186D, transcriptional inTo examine a subset of the genes that, based upon the genome-wide expression analysis, were significantly afduction of GAL1 was severely impaired. A similar result was obtained following ectopic expression of Gal4p [20] , fected by the TBP-E186D mutation, we performed S1 nuclease protection analysis (Figure 2a ). For comparison, indicating that the lack of GAL1 induction was not due to suboptimal expression of Gal4p. Significantly, however, transcription of these same genes in cells expressing three other TBP interface mutants, TBP-N2-1, TBP-L189S, transcriptional induction of CUP1, SSA4, INO1, and HIS3 was unaffected by TBP-E186D. Thus, these inducibly and TBP-F184L, was analyzed in parallel. Consistent with the genome-wide expression analysis, in cells expressing expressed genes also displayed differential sensitivity to the TBP-E186D mutation. The TBP DNA binding surface TBP-E186D, transcription of all four genes (CHA1, CLN2, CYC1, and PHO11) was significantly compromised. Intermutants, TBP-F148L and TBP-L189S, supported wildtype levels of CUP1, SSA4, INO1, and HIS3 transcription estingly, in cells expressing TBP-N2-1, transcription of CHA1, CLN2, and CYC1 was relatively unaffected, and were modestly compromised for GAL1 transcription. E186D mutation, whereas ENO2 UAS -CHA1 CORE was not. In the second case, we chose GAL1 (E186D sensitive) and CUP1 (E186D insensitive). Figure 3b shows that CUP1 UAS -GAL1 CORE was transcriptionally induced to high levels, whereas transcription of the reciprocal chimera, GAL1 UAS -CUP1 CORE , was severely compromised by the TBP-E186D mutation. Based upon these combined results, we conclude that the UAS, which contains the activator binding sites, confers sensitivity to the TBP-E186D mutation.
Our results show that mutation in the TBP-TFIIB interface affects a subset of genes and that the UAS, which contains the activator binding sites, confers sensitivity to the TBP-E186D mutation. A yeast TFIIB mutant, TFIIB-S53P, exhibits promoter-specific activation defects resulting, at least in part, from a failure to interact with certain activation domains [10] . To examine the relationship between genes affected by TBP-E186D and TFIIB-S53P, we performed genome-wide expression analysis using high-density DNA oligonucleotide arrays on a yeast strain expressing TFIIB-S53P. Of 6559 genes tested, transcription of approximately 9% was decreased 2-fold or greater. Interestingly, several of the most affected genes are involved in the pheromone response pathway. Figure 4a shows that, following the addition of ␣ mating factor, transcriptional activation of BAR1, FUS3, MFA, and SST2 was severely impaired in a strain expressing TFIIB-S53P. In contrast, in a strain expressing TBP-E186D, transcriptional activation of these genes was comparable to wild-type.
We next compared the data from genome-wide expression analysis between TBP-E186D and TFIIB-S53P. Significantly, transcription of only a small number of genes was impaired in both mutants ‫%5ف(‬ of the genes affected by the TFIIB-S53P mutation). Of those genes affected by by S1 nuclease protection and was used as a normalization control.
Here, we isolate and characterize a new TBP mutant compromised for interaction with TFIIB and exhibiting a series of promoter-specific activation defects. Previously, The promoter-specific requirement for various transcriptional components has been mapped either to the UAS Lee and Struhl [17] analyzed several yeast TBP mutants compromised for interaction with TFIIB and found that (upstream activating sequence) or to the core promoter (see, for examples, [21, 22] ). To determine whether the a small number of genes tested were transcribed normally. There are several significant differences between our UAS or the core promoter confers sensitivity to the TBP-E186D mutation, we constructed chimeras using promotstudy and that of Lee and Struhl (1997), which likely accounts for their failure to observe activation defects. ers that were either sensitive or insensitive to the TBP-E186D mutation. In one case, we chose CHA1 (E186D First, Lee and Struhl [17] analyzed several directed TBP mutations, whereas we randomly mutated the three resisensitive) and ENO2 (E186D insensitive). As shown in Figure 3a , CHA1
UAS -ENO2
CORE was sensitive to the TBPdues that mediate interaction with TFIIB and screened for activation-defective mutants. Second, Lee and Struhl growth, and even this substitution resulted in a slow-growth phenotype. If more severe mutations at TBP-E186 could [17] monitored only a few genes, whereas we performed genome-wide expression analysis. Finally, we note that be analyzed in a comparable fashion, it seems likely that they would have a more general transcriptional defect. our findings are supported by the isolation of human TFIIB mutants that interfere with the TBP-TFIIB interaction and are differentially responsive to activators [23] .
It has been suggested that sensitivity to mutations that disrupt a specific protein-protein or protein-DNA interaction can reveal the rate-limiting step(s) in PIC assembly Significantly, both our study and that of Lee and Struhl [17] found that most TBP mutants defective for interaction [15, 17, 18] . If this supposition is correct, our results indicate that the TBP-TFIIB interaction is rate limiting at with TFIIB failed to support cell growth, reflecting a severe transcriptional impairment of some genes. In fact, at TBPcertain promoters. However, we believe that this experimental approach is not sufficient to draw a rigorous conclu-E186, only a conservative substitution supported cell rate-limiting step of PIC assembly (e.g., the TBP-TFIIB 
